Inhibiting JAK3 reduces the production of pro-inflammatory cytokines such as interleukin-6 and interleukin-17, which are two important cytokines in rheumatoid arthritis (Henderson Berg et al., 2022; Kotyla et al., 2022). The gene discussed is JAK3; the disease is rheumatoid arthritis.